Page last updated: 2024-11-07

phenylalanyl-leucyl-arginyl phenylalaninamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenylalanyl-leucyl-arginyl phenylalaninamide: RN given refers to all (L)-isomer; RN for cpd without isomeric designation not avail 11/90; involved in transmitter release [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121915
MeSH IDM0181611

Synonyms (8)

Synonym
flrfamide
80690-77-3
(2s)-n-[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanamide
phenylalanyl-leucyl-arginyl phenylalaninamide
l-phenylalaninamide, l-phenylalanyl-l-leucyl-l-arginyl-
h-phe-leu-arg-phe-nh2
DTXSID001001417
2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]-n-{5-carbamimidamido-1-hydroxy-1-[(1-hydroxy-1-imino-3-phenylpropan-2-yl)imino]pentan-2-yl}-4-methylpentanimidic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" For agonist studies, full dose-response curves were generated and analyzed for potency and efficacy (maximal percent effect)."( The effect of FMRFamide analogs on [35S]GTP-gamma-S stimulation in squid optic lobes.
Heyliger, SO; Payza, K; Rothman, RB, 1998
)
0.3
" FMRFamide and FLRFamide had similar dose-response curve patterns with thresholds at 10(-9) mol l(-1) but FLRFamide was more potent than FMRFamide."( Excitation evoked by FMRFamide and FLRFamide in the heart of Buccinum undatum and evidence for inositol 1,4,5-trisphosphate as an RF-tetrapeptide second messenger.
Ellis, AM; Huddart, H, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's21 (53.85)18.2507
2000's15 (38.46)29.6817
2010's3 (7.69)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.58 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]